These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 11900348)
1. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine. Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-herpetic activity of phosphoramidate ProTides. Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629 [TBL] [Abstract][Full Text] [Related]
3. A thymidine phosphorylase-stable analogue of BVDU with significant antiviral activity. Guenther S; Balzarini J; De Clercq E; Nair V J Med Chem; 2002 Dec; 45(25):5426-9. PubMed ID: 12459010 [TBL] [Abstract][Full Text] [Related]
4. Successful kinase bypass with new acyclovir phosphoramidate prodrugs. McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue. Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs. De Clercq E; Walker RT Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses. Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds. Jones AS; Sayers JR; Walker RT; De Clercq E J Med Chem; 1988 Jan; 31(1):268-71. PubMed ID: 2826786 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral activity of the carbocyclic analogues of (E)-5-(2-halovinyl)-2'-deoxyuridines and (E)-5-(2-halovinyl)-2'-deoxycytidines. Herdewijn P; De Clercq E; Balzarini J; Vanderhaeghe H J Med Chem; 1985 May; 28(5):550-5. PubMed ID: 2985782 [TBL] [Abstract][Full Text] [Related]
10. 5-(5-Bromothien-2-yl)-2'-deoxyuridine and 5-(5-chlorothien-2-yl)-2'-deoxyuridine are equipotent to (E)-5-(2-bromovinyl)-2'-deoxyuridine in the inhibition of herpes simplex virus type I replication. Wigerinck P; Pannecouque C; Snoeck R; Claes P; De Clercq E; Herdewijn P J Med Chem; 1991 Aug; 34(8):2383-9. PubMed ID: 1652017 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral activity assay of novel (E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine. Lavandera I; Fernández S; Ferrero M; De Clercq E; Gotor V Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):833-6. PubMed ID: 14565290 [TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase. Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629 [TBL] [Abstract][Full Text] [Related]
14. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). De Clercq E Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733 [TBL] [Abstract][Full Text] [Related]
15. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine. De Clercq E J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320 [TBL] [Abstract][Full Text] [Related]
16. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? Andrei G; De Clercq E; Snoeck R Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral properties of (Z)-5-(2-bromovinyl)-2'-deoxyuridine. Jones AS; Rahim SG; Walker RT; De Clercq E J Med Chem; 1981 Jun; 24(6):759-60. PubMed ID: 6265638 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design. Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738 [TBL] [Abstract][Full Text] [Related]
19. Problems associated with the use of (E)-5-(2-bromovinyl)-2'-deoxyuridine for typing herpes simplex virus. Swierkosz EM; Arens MQ; Rivetna KA J Clin Microbiol; 1985 Mar; 21(3):459-61. PubMed ID: 2984249 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of 1-(2-deoxy-beta-D-ribofuranosyl)-2,4-difluoro-5-substituted-benzenes: "thymine replacement" analogs of thymidine for evaluation as anticancer and antiviral agents. Wang ZX; Duan W; Wiebe LI; Balzarini J; De Clercq E; Knaus EE Nucleosides Nucleotides Nucleic Acids; 2001; 20(1-2):41-58. PubMed ID: 11303562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]